Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
While GLP-1s are highly effective and drive profound health impacts, low rates of adherence mean employers and health plans are increasingly stuck with rising GLP-1 costs, but without the intended health outcomes and savings
FTC and Advertising Compliance The FTC side is simpler than founders make it, which is probably why they keep messing it up
The cardiovascular outcomes trial SUSTAIN-6, published in the New England Journal of Medicine, demonstrated cardiovascular safety in a population where many participants were receiving antiplatelet therapy
We're constantly sharing knowledge to help the research community thrive
US$ 20.97
US$ 25.10
US$ 21.12
